4//SEC Filing
Leftwich Scott 4
Accession 0001493152-24-041199
CIK 0001855485other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 9:14 PM ET
Size
6.2 KB
Accession
0001493152-24-041199
Insider Transaction Report
Form 4
Leftwich Scott
Director
Transactions
- Award
Non-Qualified Stock Options (right to buy)
2024-09-20+20,217→ 20,217 totalExercise: $1.09Exp: 2034-09-20→ Common stock (20,217 underlying)
Footnotes (1)
- [F1]On October 11, 2024, pursuant to the issuer's 2023 Equity Incentive Plan, the reporting person was issued a non-qualified stock option to purchase 20,217 shares of common stock (the "Options") at an exercise price of $1.09, which is the closing price of the issuer's common stock on the grant date, September 20, 2024 (the "Grant Date"). The Options shall vest, and become exercisable, in 1/12th per month installments over one year commencing on the Grant Date.
Documents
Issuer
Calidi Biotherapeutics, Inc.
CIK 0001855485
Entity typeother
Related Parties
1- filerCIK 0001991668
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 9:14 PM ET
- Size
- 6.2 KB